# Correlation of Endothelial Function and Early Coronary Artery Disease in Humans

> **NCT00271492** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 200 (actual)

## Conditions studied

- Endothelial Dysfunction

## Interventions

- **DRUG:** Atrasentan
- **DRUG:** Atrasentan
- **DRUG:** atrasentan

## Key facts

- **NCT ID:** NCT00271492
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2006-06
- **Final completion:** 2008-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2010-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271492, "Correlation of Endothelial Function and Early Coronary Artery Disease in Humans". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00271492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*